Gastric carcinoma

Gastric carcinoma is a malignant tumor arising from the epithelial cells lining the stomach, representing the most common primary stomach tumor in cats. While gastric neoplasia is relatively rare in feline patients compared to many other cancers, it carries significant clinical importance due to its typically advanced stage at diagnosis, its profound effects on nutritional status, and its generally poor prognosis. Adenocarcinoma is the most frequently encountered histological type, arising from the glandular cells of the stomach mucosa. This aggressive cancer typically affects older cats, with most cases diagnosed in felines over ten years of age, though younger cats can occasionally be affected. Some studies have suggested a possible predisposition in Siamese cats, though this finding requires further confirmation.

Gastric carcinoma develops when the normal epithelial cells of the stomach lining undergo malignant transformation, leading to uncontrolled cell growth and tumor formation. The exact triggers for this transformation in cats remain incompletely understood, though chronic gastric inflammation has been proposed as a potential contributing factor. The tumor typically arises in the pyloric region or lesser curvature of the stomach, areas where it can progressively obstruct gastric outflow and interfere with normal digestive function. Gastric carcinomas often grow both into the stomach lumen and outward into surrounding tissues, and they have a strong tendency to metastasize to regional lymph nodes, liver, and other abdominal structures by the time of diagnosis.

The impact of gastric carcinoma on affected cats is profound and multifaceted. As the tumor grows, it progressively impairs the stomach's ability to function normally, leading to vomiting, weight loss, and nutritional deficiencies. Ulceration of the tumor surface causes chronic bleeding that can result in anemia. Obstruction of gastric outflow causes food retention, distension, and increasingly severe vomiting. The systemic effects of cancer, including inflammation and metabolic changes, contribute to progressive debilitation. By the time most gastric carcinomas are diagnosed, affected cats have already experienced significant decline in body condition and quality of life, emphasizing the importance of prompt investigation when concerning symptoms develop.

Treatment options for feline gastric carcinoma depend heavily on the extent of disease at diagnosis and the cat's overall condition. Surgical resection offers the best potential for extended survival when the tumor can be completely removed, though this is often not possible due to tumor location, local invasion, or metastatic spread. Chemotherapy may provide additional benefit in some cases, though the response of feline gastric carcinoma to chemotherapeutic agents has been variable. Palliative care focuses on managing symptoms and maintaining comfort when curative treatment is not feasible. The prognosis for gastric carcinoma in cats is generally guarded to poor, though early detection and aggressive treatment can occasionally achieve meaningful survival times in selected cases.

The precise causes of gastric carcinoma in cats remain an area of ongoing veterinary research, with no single definitive causative agent identified. Unlike human gastric cancer, where Helicobacter pylori infection has been established as a major risk factor, the role of Helicobacter species in feline gastric carcinoma is less clear. While various Helicobacter organisms have been found in cat stomachs, a direct causal link to cancer development has not been definitively established in this species. Current understanding suggests that gastric carcinoma likely develops through a complex interplay of factors that promote chronic cellular damage, inflammation, and eventual malignant transformation of gastric epithelium.

Chronic gastric inflammation may contribute to the development of gastric carcinoma over time. Persistent inflammatory conditions of the stomach create an environment of ongoing tissue damage and repair that could theoretically promote the genetic changes leading to cancer. Chronic gastritis from various causes, including dietary factors, immune-mediated processes, or infectious agents, subjects the gastric mucosa to repeated injury and regeneration. Each cycle of damage and repair provides opportunity for genetic errors to accumulate in dividing cells. While the strength of this association in cats is not as clearly established as in some other species, chronic inflammation remains a plausible contributing factor to gastric carcinoma development.

Dietary factors have been investigated as potential contributors to gastric cancer in various species, though specific dietary associations in cats have not been clearly identified. In humans, high salt intake, consumption of preserved and smoked foods, and low fresh fruit and vegetable consumption have been linked to gastric cancer risk. Whether similar associations exist for cats is unknown, as feline diets differ substantially from human diets and relevant studies in cats are limited. Exposure to certain dietary carcinogens or nutritional deficiencies affecting mucosal integrity could theoretically contribute to cancer risk, but specific culprits have not been identified.

Age represents the most consistently identified risk factor for gastric carcinoma in cats, with most cases occurring in cats over ten years of age. The relationship between aging and cancer development is well established and involves accumulated genetic damage over time, declining immune surveillance against abnormal cells, and changes in cellular repair mechanisms. Older cats have experienced more potential carcinogenic exposures, more episodes of gastric inflammation and repair, and may have reduced ability to identify and eliminate precancerous cells before they become established tumors. This age-related risk underscores the importance of investigating gastrointestinal symptoms thoroughly in senior cats.

The mechanism by which gastric carcinoma develops involves progressive genetic and molecular changes in gastric epithelial cells that lead to loss of normal growth controls. Mutations accumulate in genes regulating cell division, cell death, and tissue organization. As cells acquire these abnormalities, they begin to proliferate abnormally, initially forming premalignant changes and eventually developing into invasive cancer. Gastric adenocarcinomas typically develop from glandular cells of the gastric mucosa and may initially grow as polypoid masses or as diffuse thickening of the stomach wall. The tumor's ability to invade locally into deeper layers of the stomach wall and spread to distant sites through lymphatic and blood vessels determines its clinical behavior and prognosis.

The early warning signs of gastric carcinoma in cats are often subtle and nonspecific, contributing to the frequent late-stage diagnosis of this cancer. Initial symptoms may be attributed to common, less serious gastrointestinal issues, delaying the more thorough investigation that could lead to earlier detection. Cats may first show slight decreases in appetite, becoming more selective about food or eating smaller amounts than usual. Occasional episodes of vomiting may be dismissed as hairballs or dietary indiscretion. Mild weight loss may go unnoticed initially or be attributed to normal aging. These vague early signs typically develop gradually over weeks to months, making the onset of illness difficult to pinpoint.

Vomiting represents the most common and characteristic symptom of gastric carcinoma in cats. The vomiting may initially be intermittent and may seem to respond temporarily to symptomatic treatment, only to return and become increasingly frequent and severe. As the tumor grows and progressively obstructs gastric outflow, vomiting becomes more persistent and occurs shortly after eating. The vomit may contain undigested food consumed hours earlier, reflecting gastric retention. Blood may be present in the vomit, appearing either as fresh red blood or as dark, digested material resembling coffee grounds. The chronic vomiting leads to loss of fluids, electrolytes, and nutrients, contributing to the cat's progressive decline.

Behavioral changes accompany the physical symptoms of gastric carcinoma. Affected cats typically show progressive loss of appetite that may begin as increased selectivity about food before advancing to more complete anorexia. Lethargy and decreased activity develop as the cat becomes debilitated from nutritional deficiencies and the systemic effects of cancer. Some cats become withdrawn and seek out isolated resting spots. Others may show signs of abdominal discomfort, including reluctance to be picked up or handled around the abdomen. Changes in posture, with the cat appearing hunched or adopting a praying position, may indicate abdominal pain. Previously social cats may become more reclusive as they feel increasingly unwell.

Physical signs of gastric carcinoma often reflect the systemic effects of chronic illness and malnutrition. Progressive weight loss is typical and may be substantial by the time of diagnosis, with visible loss of muscle mass and body fat. The coat may become dull and unkempt as grooming behavior decreases. Dehydration develops from the combined effects of vomiting and decreased water intake. Pale gums may indicate anemia from chronic gastric bleeding. Abdominal palpation may reveal a thickened stomach or detectable mass in some cases, though this finding requires veterinary assessment. Weakness and decreased energy become increasingly apparent as the disease progresses.

As gastric carcinoma advances, symptoms intensify and complications may develop. Vomiting becomes more frequent and severe, with larger volumes and more obvious blood content. Complete gastric obstruction may occur, causing severe distension and unrelenting vomiting. Perforation of the tumor, though uncommon, can cause sudden severe abdominal pain and collapse from peritonitis. Signs of metastatic disease may become apparent, including abdominal distension from fluid accumulation, difficulty breathing from lung involvement, or other symptoms depending on sites of spread. The cat's overall condition deteriorates progressively, with worsening weakness, dehydration, and debilitation.

Certain symptoms associated with gastric carcinoma require immediate veterinary attention. Severe or projectile vomiting, especially with large volumes of blood, indicates a potentially life-threatening situation. Sudden onset of severe abdominal pain with collapse may indicate tumor perforation or other acute complication. Signs of severe dehydration, including extreme lethargy, sunken eyes, and dry gums, require urgent fluid support. Cats who cannot keep any food or water down for more than twenty-four hours need immediate evaluation. Black, tarry stool indicating significant gastrointestinal bleeding warrants prompt investigation. Any sudden severe deterioration should prompt emergency veterinary care rather than watchful waiting.

The diagnostic process for gastric carcinoma typically begins when persistent vomiting, weight loss, or other concerning gastrointestinal symptoms prompt veterinary evaluation. The veterinarian performs a thorough physical examination, assessing body condition, hydration status, and carefully palpating the abdomen for masses or abnormalities. A detailed history establishes the duration and progression of symptoms, character of vomiting, appetite changes, and any previous treatments and responses. The veterinarian inquires about diet, weight changes over time, and the cat's general health status. Initial assessment may suggest gastrointestinal disease but cannot distinguish between cancer and other possible causes of similar symptoms.

Laboratory testing provides important baseline information and helps characterize the cat's overall health status. Complete blood count may reveal anemia, which often develops from chronic gastric bleeding. Low red blood cell counts may range from mild to severe depending on the amount and chronicity of blood loss. Serum biochemistry assesses organ function and may reveal electrolyte abnormalities from chronic vomiting, elevated liver enzymes if metastatic disease is present, or other metabolic derangements. Coagulation testing may be performed if significant bleeding is evident. These tests help assess the severity of systemic effects and influence treatment planning.

Imaging studies play a crucial role in identifying gastric masses and assessing disease extent. Abdominal radiographs may show abnormal gastric distension, delayed gastric emptying, or changes in stomach position suggesting a mass, but they have limited sensitivity for detecting early tumors. Abdominal ultrasound provides more detailed evaluation, allowing visualization of gastric wall thickening, masses within the stomach, and assessment for metastatic disease in lymph nodes, liver, and other abdominal structures. Contrast radiography studies, using barium or other contrast agents, can demonstrate filling defects in the stomach suggesting masses. Advanced imaging such as computed tomography may provide additional detail for surgical planning in selected cases.

Endoscopy offers direct visualization of the stomach interior and the ability to obtain tissue samples for diagnosis. Upper gastrointestinal endoscopy involves passing a flexible camera through the mouth into the stomach under anesthesia. This allows the veterinarian to see the tumor directly, assess its size and location, and identify any mucosal abnormalities. Multiple biopsy samples can be taken from suspicious areas for histopathological examination. While endoscopy is excellent for visualizing and sampling mucosal lesions, tumors growing primarily in deeper layers of the stomach wall may not be adequately sampled by this technique. In such cases, full-thickness surgical biopsy may be necessary for definitive diagnosis. Histopathological examination of biopsy samples confirms the diagnosis and identifies the specific tumor type and grade, information essential for treatment planning and prognosis.

Initial management of cats diagnosed with gastric carcinoma focuses on stabilization and supportive care before considering definitive cancer treatment. Many cats present with significant dehydration from chronic vomiting, requiring intravenous fluid therapy to restore hydration and correct electrolyte imbalances. Antiemetic medications help control nausea and vomiting, providing relief and enabling the cat to maintain some oral intake. Acid-reducing medications, including proton pump inhibitors or H2 blockers, help protect the stomach and may reduce tumor-associated bleeding. Nutritional support through highly palatable, easily digestible foods helps address nutritional deficiencies. Pain management is initiated as needed. Once stabilized, the veterinary team develops a comprehensive treatment plan based on tumor characteristics and the individual patient's situation.

Surgical resection offers the best potential for extended survival when gastric carcinoma can be completely removed. Partial gastrectomy, removing the portion of the stomach containing the tumor along with adequate margins, may be possible for some tumors. Surgery is most likely to be successful for tumors that are localized, not invading critical structures, and without evidence of metastatic spread. The surgical procedure requires experienced surgeons and carries inherent risks related to anesthesia and the complexity of gastric surgery. Unfortunately, many cats are not surgical candidates at diagnosis due to tumor location, extent of local invasion, metastatic disease, or poor overall condition. When complete resection is achieved, surgery may be combined with additional treatments.

Chemotherapy may be considered as an adjunct to surgery or as primary treatment for cats with inoperable disease. The response of feline gastric carcinoma to chemotherapeutic agents has not been well characterized due to the relative rarity of this tumor, and no standard protocol has been established. Agents that have been used include various combinations commonly employed for gastrointestinal carcinomas in veterinary patients. Chemotherapy is typically administered at intervals over several weeks to months. The goal may be to reduce tumor size before surgery, to address microscopic disease remaining after surgery, or to control tumor growth and manage symptoms when surgery is not feasible. Side effects are generally manageable but require monitoring.

Palliative care plays a crucial role for cats with gastric carcinoma, whether as primary treatment when aggressive therapy is not pursued or as supportive care alongside other treatments. Medical management of symptoms aims to improve quality of life and maintain comfort. Antiemetics and anti-nausea medications reduce vomiting and improve appetite. Acid-suppressing medications help control gastric ulceration and bleeding. Pain management addresses discomfort from the tumor and its effects. Nutritional support through appetite stimulants, assisted feeding, or feeding tubes helps maintain caloric intake and body condition. Fluid therapy at home may be needed to maintain hydration in cats with ongoing losses.

Alternative approaches may be considered in selected situations. Radiation therapy is not typically used for gastric carcinoma due to the stomach's location and the difficulty of delivering adequate radiation doses without damaging surrounding organs. Palliative surgical procedures, such as bypass of an obstructed pylorus, may be considered when tumor removal is not possible but obstruction is causing severe symptoms. Placement of feeding tubes directly into the small intestine may allow nutritional support when gastric function is severely compromised. These interventions focus on symptom relief rather than cancer control.

Treatment decisions for gastric carcinoma must consider multiple factors unique to each situation. The extent of disease at diagnosis, including presence or absence of metastases, strongly influences treatment options and expected outcomes. The cat's overall health status and ability to tolerate surgery or chemotherapy affects what interventions are appropriate. Owner preferences regarding treatment intensity, quality of life priorities, and financial considerations legitimately influence the treatment plan. Honest discussions about prognosis help owners make informed decisions that align with their values while prioritizing their cat's wellbeing.

Recovery expectations following treatment for gastric carcinoma vary considerably depending on the treatment approach, extent of disease, and individual response. Cats undergoing surgical resection require several days of hospitalization for post-operative monitoring, pain management, and supportive care. The immediate post-operative period focuses on maintaining hydration, managing pain, monitoring for complications such as dehiscence or leakage at surgical sites, and gradually reintroducing oral feeding. Small, frequent meals of bland, easily digestible food are offered initially, with gradual return to normal feeding over days to weeks. Some cats adapt well to life with a smaller stomach, while others may require long-term dietary modifications such as smaller, more frequent meals.

Post-treatment care requirements extend beyond the immediate recovery period. Cats who have undergone gastric surgery or chemotherapy need regular veterinary monitoring to assess healing, watch for complications, and detect any signs of tumor recurrence. Follow-up examinations and imaging studies are typically scheduled at intervals, with frequency depending on the specific situation. Ongoing medications may include acid suppressants, antiemetics as needed, and supportive supplements. Nutritional management remains important, with attention to maintaining adequate caloric intake and body weight. Owners play crucial roles in monitoring daily appetite, vomiting episodes, weight, and overall status.

The prognosis for cats with gastric carcinoma is generally guarded to poor, reflecting the typically advanced stage at diagnosis and the aggressive biology of this cancer. Cats who undergo complete surgical resection with no evidence of metastatic disease have the best prognosis, though published survival data specific to feline gastric carcinoma is limited. Some cats may achieve survival times of several months to a year or more following successful surgery, particularly for lower-grade tumors. Cats with incomplete resection, metastatic disease, or inoperable tumors have more limited prognosis, often measured in weeks to a few months with supportive care. Individual outcomes vary, and discussions with the veterinary team help establish realistic expectations.

The long-term outlook requires realistic expectations while maintaining focus on quality of life for whatever time remains. Even with successful initial treatment, recurrence of gastric carcinoma is common, and ongoing vigilance is needed. Some cats experience meaningful periods of quality life following treatment, enjoying eating, comfortable rest, and interaction with family. Others may have more limited time but can still benefit from care that keeps them comfortable. The focus throughout long-term management remains on ensuring that cats experience more good days than difficult ones. Regular reassessment of quality of life helps guide decisions about continuing or adjusting treatment. When quality of life cannot be maintained, compassionate end-of-life decisions provide peaceful conclusion to suffering.

True prevention of gastric carcinoma in cats is not currently possible given our incomplete understanding of what causes this cancer to develop. Unlike some cancers with clear preventable causes, gastric carcinoma appears to arise through complex mechanisms that cannot be entirely controlled. No specific dietary factors, environmental exposures, or lifestyle modifications have been definitively shown to prevent gastric cancer development in cats. This reality emphasizes the importance of early detection rather than primary prevention, as catching tumors at earlier stages generally provides better treatment options and outcomes.

Maintaining good gastrointestinal health may help reduce conditions that could potentially contribute to gastric cancer development. Prompt treatment of any vomiting, gastritis, or other stomach issues prevents chronic inflammatory conditions that could theoretically contribute to malignant transformation over time. Addressing gastrointestinal symptoms early rather than dismissing them as minor helps ensure that any significant underlying problems are identified promptly. Regular deworming and parasite prevention maintains gastrointestinal health. While these measures cannot specifically prevent gastric carcinoma, supporting gastrointestinal health contributes to overall wellbeing.

Dietary considerations, while not proven to prevent gastric cancer, support overall gastrointestinal health. Feeding a complete and balanced commercial diet appropriate for the cat's life stage provides essential nutrients. Avoiding abrupt diet changes helps maintain stable gastrointestinal function. Ensuring access to fresh, clean water supports hydration and normal digestive function. Avoiding foods known to be irritating or toxic to cats prevents unnecessary gastrointestinal stress. Some owners prefer natural or minimally processed diets, though evidence specifically relating dietary choices to gastric cancer prevention is lacking. Any significant dietary changes should be discussed with a veterinarian.

Regular veterinary care provides the foundation for early detection that can improve outcomes when gastric carcinoma does develop. Annual wellness examinations, increasing to twice yearly for senior cats, allow veterinarians to assess body condition and detect subtle changes that might indicate developing problems. Blood work as part of wellness screening can reveal anemia or other abnormalities warranting investigation. Owners should monitor their cats for gastrointestinal symptoms and report persistent vomiting, decreased appetite, or weight loss promptly rather than assuming these are minor issues. Early investigation of concerning symptoms provides the best opportunity for detecting problems at treatable stages.

Early intervention when gastrointestinal symptoms persist maximizes treatment options if gastric carcinoma is detected. Cats with chronic vomiting that does not respond fully to standard treatments should be evaluated thoroughly, including endoscopy if indicated. Weight loss without clear explanation warrants investigation. Owners of senior cats should be particularly attentive to changes in eating behavior and body condition. Working closely with a veterinarian ensures that concerning symptoms receive appropriate attention rather than being dismissed as normal aging. While early detection cannot guarantee successful treatment, it provides the best opportunity for meaningful intervention.

Daily management of a cat diagnosed with gastric carcinoma requires careful attention to feeding, medication administration, symptom monitoring, and quality of life assessment. Feeding strategies often need modification to accommodate reduced gastric capacity and function. Small, frequent meals spread throughout the day may be better tolerated than larger meals. Highly palatable, easily digestible foods encourage eating and minimize digestive stress. Some cats prefer warmed food with enhanced aroma. Elevated feeding stations may make eating more comfortable. Tracking food intake helps identify trends and alerts owners to declining appetite. Ensuring adequate nutrition is challenging but important for maintaining strength and quality of life.

Medication management is typically necessary for cats with gastric carcinoma. Antiemetic medications help control nausea and vomiting, improving comfort and enabling the cat to eat. Acid-suppressing medications protect the stomach lining and may reduce tumor-associated bleeding. Pain medications address discomfort. Establishing a consistent medication routine ensures compliance. Owners should understand the purpose of each medication, watch for potential side effects, and communicate any concerns to the veterinary team. Some medications may be given with food while others require specific timing relative to meals.

Maintaining quality of life remains the central goal of management for cats with gastric carcinoma. Good quality of life involves the ability to eat comfortably, rest peacefully, engage with family, and experience pleasure without excessive nausea, pain, or distress. Signs of maintained quality include voluntary eating even if amounts are small, comfortable resting, continued response to family members, and absence of constant discomfort. Warning signs of declining quality include persistent nausea despite medication, complete loss of appetite, constant pain or distress, and withdrawal from all interaction. Regular honest assessment helps ensure that management decisions continue to serve the cat's best interests.

Ongoing monitoring for disease progression and treatment complications requires vigilance. Changes in vomiting frequency, character, or volume may indicate tumor progression or other problems. Blood in vomit or stool suggests active gastric bleeding. Declining appetite, progressive weight loss, or worsening body condition reflects advancing disease. New symptoms such as difficulty breathing or abdominal distension may indicate metastatic spread or complications. Regular veterinary examinations and periodic testing help track disease status objectively. Between visits, owners serve as essential observers, maintaining a low threshold for contacting the veterinary team when concerns arise.

Caring for a cat with serious gastrointestinal cancer takes significant emotional and practical toll on owners. The challenges of managing feeding, medications, and symptoms require daily attention and can be stressful. Watching a beloved pet deal with nausea and declining appetite is difficult emotionally. Financial costs of ongoing care add practical stress. Connecting with supportive resources, including veterinary social workers or support communities, provides valuable assistance. Honest communication with the veterinary team about concerns and values ensures that care decisions align with what matters most. When quality of life can no longer be maintained despite best efforts, preparing emotionally for end-of-life decisions helps owners navigate this final challenge with love and compassion.

Gastric carcinoma in cats has been suggested to occur with possible increased frequency in Siamese cats based on some studies, though this association requires further confirmation through larger epidemiological investigations. The basis for any breed predisposition is not well understood and could relate to genetic factors influencing cancer susceptibility or perhaps to other characteristics of the breed. If a true predisposition exists, it is likely to be modest rather than dramatically elevated compared to other breeds. Both purebred and mixed-breed cats can develop gastric carcinoma, and the majority of cases occur in domestic shorthair and domestic longhair cats simply due to their predominance in the general cat population.

Aside from the possible Siamese association, no other breed predispositions have been consistently identified for feline gastric carcinoma. The relatively low incidence of this cancer in cats overall limits the ability to detect breed associations that might exist. Age represents a far stronger risk factor than breed, with most cases occurring in cats over ten years of age regardless of breed background. No sex predisposition has been clearly established, with males and females affected relatively equally. Individual health history and possibly environmental factors may influence risk more than breed heritage for most cats.

Given the limited breed-specific risk information available, screening recommendations for gastric carcinoma focus on age-based and symptom-based approaches rather than breed-specific protocols. All senior cats benefit from regular veterinary examinations that include assessment of body weight and gastrointestinal health. Owners should monitor their cats for persistent vomiting, decreased appetite, or unexplained weight loss and report these symptoms promptly. Owners of Siamese cats may wish to be particularly attentive to gastrointestinal symptoms given the possible breed association, though all aging cats deserve vigilant monitoring. Early investigation of concerning symptoms provides the best opportunity for detecting gastric tumors at stages when treatment may be more effective.

Several conditions commonly co-occur with or require differentiation from gastric carcinoma in cats. Inflammatory bowel disease, a common cause of chronic gastrointestinal symptoms, may be present in cats who develop gastric cancer and can produce similar symptoms. Chronic kidney disease frequently occurs in older cats and contributes to nausea and vomiting that may complicate the clinical picture. Hyperthyroidism, another common geriatric feline condition, causes vomiting and weight loss that overlap with cancer symptoms. Hepatic or pancreatic disease may co-exist or develop secondarily to gastric tumors. Managing these concurrent conditions adds complexity to treatment and affects prognosis.

Several other conditions cause similar gastrointestinal symptoms and must be differentiated from gastric carcinoma through appropriate diagnostic testing. Other gastric tumors, including lymphoma and less common tumor types, present similarly and require biopsy for differentiation. Gastric foreign bodies can cause chronic vomiting mimicking tumor symptoms. Inflammatory conditions such as chronic gastritis produce similar signs. Motility disorders affecting gastric emptying cause vomiting and food retention. Systemic diseases including kidney failure and pancreatitis cause gastrointestinal symptoms. Accurate diagnosis ensures appropriate treatment for the specific underlying condition rather than misdirected therapy.

Complications arising from gastric carcinoma require recognition and management as the disease progresses. Gastric outflow obstruction from tumor growth causes increasingly severe vomiting and distension. Tumor ulceration leads to chronic bleeding and progressive anemia. Perforation, though uncommon, causes peritonitis requiring emergency intervention. Metastatic spread to lymph nodes, liver, lungs, and peritoneal surfaces indicates disease progression and generally worsens prognosis. Malnutrition and debilitation develop from chronic inability to maintain adequate nutrition. Recognizing these complications allows for appropriate adjustment of the care plan, whether that involves additional interventions to manage specific problems or transition toward comfort-focused care as the cat's condition evolves.